Trials / Completed
CompletedNCT01893528
Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Regeneron Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a phase 1, randomized, double-blind, placebo-controlled first-in-human (FIH) study to assess the safety and tolerability of ascending single doses of REGN2009 administered to healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | REGN2009 | |
| OTHER | placebo |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2013-07-09
- Last updated
- 2014-11-10
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01893528. Inclusion in this directory is not an endorsement.